EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01952 EVEREST MED

Closed National Day 09-30 16:08:27

30.140

+2.160

+7.72%

High30.480	Low28.020	Vol9.34M
Open28.020	D1 Closing27.980	Amplitude8.79%
Mkt Cap10.67B	Tradable Cap10.67B	Total Shares354.00M
T/O277.40M	T/O Rate2.64%	Tradable Shares354.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01952","market":"HK","secType":"STK","nameCN":"EVEREST MED","latestPrice":30.14,"timestamp":1790755707003,"preClose":27.98,"halted":0,"volume":9335234,"delay":0,"changeRate":0.07719799857040743,"floatShares":354000000,"shares":354000000,"eps":-0.89,"marketStatus":"Closed National Day","change":2.16,"latestTime":"09-30 16:08:27","open":28.02,"high":30.48,"low":28.02,"amount":277403591,"amplitude":0.08792,"askPrice":30.2,"askSize":3500,"bidPrice":30.14,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":-0.175,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1602172800000,"exchange":"SEHK","adjPreClose":27.98,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":2.309079528314762,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01952/wiki","defaultTab":"wiki","newsList":[{"id":"2672755958","title":"Everest Medicines Stock In Focus After China Approval For CARDAMYST","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755958","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755958?lang=en_us&edition=fundamental","pubTime":"2026-10-01 16:17","pubTimestamp":1790842633,"startTime":"0","endTime":"0","summary":"Everest Medicines has secured NMPA approval in China for CARDAMYST, a self-administered etripamil nasal spray for acute PSVT episodes, supported by multiple studies showing rapid rhythm conversion, at-home use, and generally mild side effects.\nThe launch of CARDAMYST as Everest Medicines' first cardiovascular therapy moves the business into a new treatment area with a large PSVT and AFib RVR patient pool across Greater China.\nWe will now look at how Everest Medicines' investment narrative...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-stock-in-focus-after-china-approval-for-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1161","BK1574","01952","MDCO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154987922","title":"Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1154987922","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154987922?lang=en_us&edition=fundamental","pubTime":"2026-09-30 10:02","pubTimestamp":1790733739,"startTime":"0","endTime":"0","summary":"mRNA concept stocks are leading the gains, with CanSinoBIO (06185) rising 16.78% to HK$36.32 as of press time.Everest Medicines (01952) is up 4.29% at HK$29.18, 3D Medicines (01244) has gained 1.94%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","01244","BK1191","07666","VXUS","BK1161","BK4588","BK1574","KCAI","01952","06185","BK4585","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189388761","title":"Movement Alert｜EVEREST MED Rises 5.72% in Regular Trading, Medical Industry Policy and mRNA Pipeline Progress Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1189388761","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189388761?lang=en_us&edition=fundamental","pubTime":"2026-09-30 09:52","pubTimestamp":1790733173,"startTime":"0","endTime":"0","summary":"On September 30, EVEREST MED (01952.HK) rose 5.72% in regular trading, trading at HKD 29.62/share, with turnover of HKD 60.70 million.On the news front, ten government departments jointly released...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Rises on Medical Industry Development Plan","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168669730","title":"Everest Medicines Sets Up ESG Committee, Names Four Directors Including Chairman Yifang Wu","url":"https://stock-news.laohu8.com/highlight/detail?id=1168669730","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168669730?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:43","pubTimestamp":1790606603,"startTime":"0","endTime":"0","summary":"Everest Medicines announced the formation of an Environmental, Social and Governance (ESG) Committee, effective 28 September 2026. The new board‐level body will comprise at least three members and...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172375210","title":"Everest Medicines Establishes ESG Committee to Strengthen Sustainability Governance","url":"https://stock-news.laohu8.com/highlight/detail?id=1172375210","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172375210?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:41","pubTimestamp":1790606481,"startTime":"0","endTime":"0","summary":"Everest Medicines Limited (EVEREST MED) has formed an Environmental, Social and Governance (ESG) Committee following a board resolution dated 28 September 2026. The new body is tasked with steering...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140049460","title":"Everest Medicines Forms ESG Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1140049460","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140049460?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:06","pubTimestamp":1790604372,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) has announced the establishment of an Environmental, Social and Governance Committee, effective from September 28, 2026.The ESG Committee shall consist of no fewer than...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1583","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122725078","title":"Movement Alert｜EVEREST MED Declines 5.04% in Regular Trading, Trading at HK$27.54","url":"https://stock-news.laohu8.com/highlight/detail?id=1122725078","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122725078?lang=en_us&edition=fundamental","pubTime":"2026-09-24 10:16","pubTimestamp":1790216198,"startTime":"0","endTime":"0","summary":"On September 24, EVEREST MED fell 5.04% in regular trading, trading at HK$27.54 per share, with turnover of HK$65.82 million.Within the Biotechnology sector where EVEREST MED belongs, the sector...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185116997","title":"HK Movers | Biotech Names Firmed: CANSINOBIO up Nearly 10%, JW THERAP-B up More Than 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185116997","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185116997?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:14","pubTimestamp":1790133252,"startTime":"0","endTime":"0","summary":"Hong Kong biotech names firmed: $CANSINOBIO(06185)$ up nearly 10%, $JW THERAP-B(02126)$ up more than 7%, $EVEREST MED(01952)$ and $CSTONE PHARMA-B(02616)$ also advanced.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02616","02126","01952","06185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115568652","title":"Movement Alert｜EVEREST MED Rises 5.23% in Regular Trading, Weshiping Domestic Production Registration Accepted with Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1115568652","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115568652?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:43","pubTimestamp":1790131403,"startTime":"0","endTime":"0","summary":"On September 23, EVEREST MED rose 5.23% in regular trading, trading at 30.08 HKD/share, with turnover of approximately 90.17 million HKD. The rally was driven by multiple converging catalysts...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Surges as Weshiping Domestic Production Gets Priority Review","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125223612","title":"HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125223612","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125223612?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:59","pubTimestamp":1789955946,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks rose across the board. $LEPU BIO(02157)$, $INNOCARE(09969)$ and $AKESO(09926)$ gained over 7%, while $REMEGEN(09995)$, $EVEREST MED(01952)$, $INNOVENT BIO(01801)$, $GENSCRIPT BIO(01548)$ and $SKB BIO(06990)$ rose over 6%, $3SBIO(01530)$ advanced over 5%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","01952","09995","02157","06990","09969","09926","01548","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171130638","title":"Movement Alert｜EVEREST MED Rises 5.8% in Regular Trading, Velsipity Domestic Production Application Accepted with Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1171130638","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171130638?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:44","pubTimestamp":1789955073,"startTime":"0","endTime":"0","summary":"On September 21, EVEREST MED rose 5.8% in regular trading, trading at HK$29.28 per share, with turnover of HK$57.12 million.On the news front, the company announced on September 17 that the NMPA's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Everest Med Gains on Velsipity Priority Review Acceptance","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199528356","title":"Movement Alert｜EVEREST MED Rises 5.24% in Regular Trading, Drug Registration Application for Domestic Production Transfer of Weishiping Accepted","url":"https://stock-news.laohu8.com/highlight/detail?id=1199528356","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199528356?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:53","pubTimestamp":1789696424,"startTime":"0","endTime":"0","summary":"On September 18, EVEREST MED rose 5.24% in regular trading, trading at HK$27.72/share, with turnover of approximately HK$66.45 million.The move was driven by the announcement that the company's drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"EVEREST MED Rises on Weishiping Local Production Filing","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137022596","title":"Hong Kong Stock Market Alert: EVEREST MED Surges Over 5% on Regulatory Filing Acceptance for Local Production Transfer","url":"https://stock-news.laohu8.com/highlight/detail?id=1137022596","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137022596?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:38","pubTimestamp":1789695494,"startTime":"0","endTime":"0","summary":"EVEREST MED (01952) shares climbed more than 5% in early trading on Wednesday, with the stock last up 3.49% at HK$27.24, and trading volume reaching HK$27.02 million. The move comes after the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCAI","01952","BK1583","BK1161","BK1574","IPOS","BK4588","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151413097","title":"Everest Medicines Chairman Wu Yifang Boosts Stake With New Share Purchase at HK$28.71 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1151413097","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151413097?lang=en_us&edition=fundamental","pubTime":"2026-09-13 14:00","pubTimestamp":1789279246,"startTime":"0","endTime":"0","summary":"Hong Kong Stock Exchange filings show that on September 10, board chairman Wu Yifang increased his holding in EVEREST MED (01952) by 20,000 shares at an average price of HK$28.7065 per share,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","01952","EWH","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167245343","title":"Board Chairman Acquires Additional Stake in EVEREST MED with Two-Thousand-Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1167245343","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167245343?lang=en_us&edition=fundamental","pubTime":"2026-09-11 20:31","pubTimestamp":1789129862,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on September 10, the board chairman increased his position in EVEREST MED by purchasing 20,000 shares.The transaction was executed at a price of HKD...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","EWH","01952","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160387520","title":"EVEREST MED: Yifang Wu Acquires Shares, Long Position Rises to 0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160387520","media":"HK Disclosure","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160387520?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:52","pubTimestamp":1789120328,"startTime":"0","endTime":"0","summary":"On September 10, 2026, Yifang Wu bought 20,000 shares of EVEREST MED stock at an average of HKD 28.7065 per share, involving about HKD 574,130.Prior to the acquisition, Yifang Wu's long position in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165687124","title":"Movement Alert｜EVEREST MED Falls 5.39% in Regular Trading, Haisen Strategic Cooperation Raises Related-Party Transaction Concerns Amid Continued Profit-Taking","url":"https://stock-news.laohu8.com/highlight/detail?id=1165687124","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165687124?lang=en_us&edition=fundamental","pubTime":"2026-09-11 10:16","pubTimestamp":1789092981,"startTime":"0","endTime":"0","summary":"On September 11, EVEREST MED fell 5.39% in regular trading to HKD 27.06, with turnover of approximately HKD 53.33 million, marking the fourth consecutive trading day of decline. The sell-off was...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"EVEREST MED Drops on Haisen RMB3.076B Related-Party Deal Worries","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122723007","title":"Movement Alert｜EVEREST MED Falls 5.38% in Regular Trading, Post-Approval Profit-Taking on Xingbituo Continues Amid Sector Weakness","url":"https://stock-news.laohu8.com/highlight/detail?id=1122723007","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122723007?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:36","pubTimestamp":1789004192,"startTime":"0","endTime":"0","summary":"On September 10, EVEREST MED fell 5.38% in regular trading, trading at 29.32 HKD/share, with turnover of 31.71 million HKD, extending the pullback for a second consecutive session.On the news front,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"EVEREST MED Falls on Post-Approval Profit-Taking for Xingbituo","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535781","title":"Everest Medicines Unit Enters Supply, Distribution Cooperation Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535781","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535781?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:26","pubTimestamp":1788960412,"startTime":"0","endTime":"0","summary":"Everest Medicines (HKG:1952) unit Everest Medicines (China) entered into a strategic cooperation framework agreement with Hasten Biopharmaceutical.The contract is for the supply, distribution, and rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1583","01952","BK1161","MDCO","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136208620","title":"Everest Medicines seals strategic cooperation with Hasten; sets RMB3.08 billion 2028 cap on connected transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=1136208620","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136208620?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:21","pubTimestamp":1788956511,"startTime":"0","endTime":"0","summary":"Everest Medicines Limited (Everest Medicines) announced that its wholly owned PRC subsidiary entered into a Strategic Cooperation Framework Agreement with Hasten Biopharmaceutical on 9 September...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.everestmedicines.com","stockEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.072},{"period":"3month","weight":0.1783},{"period":"6month","weight":-0.2613},{"period":"1year","weight":-0.4647},{"period":"ytd","weight":-0.185}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Everest Medicines Ltd is a biopharmaceutical company primarily engaged in the discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines. The Company has built a product pipeline across renal, anti-infective, and autoimmune diseases. The Company’s products portfolio includes Nefecon (TARPEYO) using in the renal therapeutic area, XERAVA (eravacycline) using in the treatment of infections caused by susceptible gram-positive, gram-negative and anaerobic pathogens including those multidrug resistant isolates and other products. The Company conducts its business in the domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.01035},{"month":2,"riseRate":0.333333,"avgChangeRate":0.039331},{"month":3,"riseRate":0.333333,"avgChangeRate":0.002002},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.092533},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.045773},{"month":6,"riseRate":0.666667,"avgChangeRate":0.224714},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.090363},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.046758},{"month":9,"riseRate":0.5,"avgChangeRate":0.026462},{"month":10,"riseRate":0.4,"avgChangeRate":-0.024036},{"month":11,"riseRate":0.5,"avgChangeRate":0.086142},{"month":12,"riseRate":0.666667,"avgChangeRate":0.131823}],"exchange":"SEHK","name":"EVEREST MED","nameEN":"EVEREST MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest EVEREST MED(01952) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"EVEREST MED,01952,EVEREST MED股票,EVEREST MED股票老虎,EVEREST MED股票老虎国际,EVEREST MED行情,EVEREST MED股票行情,EVEREST MED股价,EVEREST MED股市,EVEREST MED股票价格,EVEREST MED股票交易,EVEREST MED股票购买,EVEREST MED股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"EVEREST MED(01952),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest EVEREST MED(01952) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}